| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 5824- | CAP, | Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level |
| - | Study, | Diabetic, | NA |
| 5846- | CAP, | Capsaicin Alters the Expression of Genetic and Epigenetic Molecules In Hepatocellular Carcinoma Cell |
| - | in-vitro, | HCC, | HepG2 |
| 1518- | CAP, | Capsaicin-mediated tNOX (ENOX2) up-regulation enhances cell proliferation and migration in vitro and in vivo |
| - | in-vitro, | CRC, | HCT116 |
| 1517- | CAP, | Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1) |
| - | in-vitro, | Bladder, | TSGH8301 | - | in-vitro, | CRC, | T24/HTB-9 |
| 2014- | CAP, | Role of Mitochondrial Electron Transport Chain Complexes in Capsaicin Mediated Oxidative Stress Leading to Apoptosis in Pancreatic Cancer Cells |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | Nor, | HPDE-6 | - | in-vivo, | PC, | AsPC-1 |
| 2015- | CAP, | CUR, | urea, | Anti-cancer Activity of Sustained Release Capsaicin Formulations |
| - | Review, | Var, | NA |
| 5879- | CAR, | Pharmacokinetic analysis of thymol, carvacrol and diallyl disulfide after intramammary and topical applications in healthy organic dairy cattle |
| - | in-vivo, | Nor, | NA |
| 5886- | CAR, | Inhibition of TRPM7 with carvacrol suppresses glioblastoma functions in vivo |
| - | in-vivo, | GBM, | U87MG | - | in-vivo, | GBM, | U251 |
| 5883- | CAR, | Safety and tolerability of carvacrol in healthy subjects: a phase I clinical study |
| - | Trial, | Nor, | NA |
| 5881- | CAR, | Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties |
| - | Review, | Nor, | NA |
| 5880- | CAR, | In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Lung, | PC9 |
| 5908- | CAR, | Carvacrol improves neurological function by inhibiting TRPM7-mediated BBB disruption and hemorrhage after TBI |
| - | in-vivo, | Nor, | NA |
| 5910- | CAR, | Oregano Phytocomplex Induces Programmed Cell Death in Melanoma Lines via Mitochondria and DNA Damage |
| - | in-vitro, | Melanoma, | B16-F10 | - | NA, | NA, | A375 |
| 5894- | CAR, | Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential |
| - | Review, | Var, | NA |
| 5892- | CAR, | SRF, | Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study |
| - | in-vivo, | HCC, | NA |
| 5891- | CAR, | SRF, | Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7 |
| - | in-vivo, | HCC, | NA |
| 5889- | CAR, | Effect of carvacrol on pulmonary function tests, and total and differential white blood cell counts in healthy volunteers: A randomized clinical trial |
| - | Trial, | Nor, | NA |
| 5929- | Catechins, | Phase I trial of oral green tea extract in adult patients with solid tumors |
| - | Trial, | Var, | NA |
| 5916- | Cats, | Chemo, | Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial |
| - | Trial, | BC, | NA |
| 5917- | Cats, | Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial |
| - | Trial, | CRC, | NA |
| 5918- | Cats, | Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors |
| - | Trial, | Var, | NA |
| 5813- | CBD, | Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis |
| - | Review, | Var, | NA |
| 5960- | CEL, | Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers |
| - | Trial, | Pca, | NA |
| 5959- | CEL, | Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-κB as a possible target |
| - | in-vitro, | Cerv, | HeLa |
| 5953- | Cela, | CUR, | The Combination of Celastrol and Curcumin Enhances the Antitumor Effect in Nasopharyngeal Carcinoma by Inducing Ferroptosis |
| - | vitro+vivo, | NPC, | NA |
| 5940- | Cela, | Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway |
| - | in-vivo, | Pca, | PC3 |
| 5952- | Cela, | Celastrol attenuates Alzheimer’s disease-mediated learning and memory impairment by inhibiting endoplasmic reticulum stress-induced inflammation and oxidative stress |
| - | in-vivo, | AD, | NA |
| 5943- | Cela, | Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases |
| - | Review, | Arthritis, | NA | - | Review, | IBD, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 5970- | CET, | Cetuximab |
| - | Review, | CRC, | NA | - | Review, | HNSCC, | NA |
| 5967- | CET, | FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer |
| - | Study, | CRC, | NA |
| 6022- | CGA, | Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against Metabolic Syndrome |
| - | Review, | Nor, | NA |
| 6019- | CGA, | immuno, | Combination immunotherapy of chlorogenic acid liposomes modified with sialic acid and PD-1 blockers effectively enhances the anti-tumor immune response and therapeutic effects |
| - | in-vivo, | Melanoma, | NA |
| 6037- | CGA, | Pharmacokinetics and brain penetration study of chlorogenic acid in rats |
| - | in-vivo, | AD, | NA | - | in-vivo, | Stroke, | NA |
| 6040- | CGA, | Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer's disease via Wnt signaling pathway |
| - | in-vivo, | AD, | NA |
| 6041- | CGA, | Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot Study |
| - | Trial, | AD, | NA |
| 6043- | CGA, | SeNPs, | Enhanced Effect of Combining Chlorogenic Acid on Selenium Nanoparticles in Inhibiting Amyloid β Aggregation and Reactive Oxygen Species Formation In Vitro |
| - | in-vitro, | AD, | NA |
| 6035- | CGA, | Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial |
| - | Trial, | Nor, | NA |
| 6029- | CGA, | Pharmacokinetics of chlorogenic acids absorbed in human plasma and their metabolites following oral ingestion of coffee drink |
| - | Trial, | Nor, | NA |
| 6028- | CGA, | Chlorogenic acids from green coffee extract are highly bioavailable in humans |
| - | Trial, | Nor, | NA |
| 6001- | Chit, | Recent advances in engineering chitosan-based nanoplatforms in biotherapeutic multi-delivery for multi-targeted disease treatments: Promises and outlooks |
| - | Review, | Var, | HepG2 | - | Review, | AD, | NA |
| 6071- | CHL, | First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent |
| - | Trial, | Nor, | NA |
| 3701- | Chol, | Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation |
| - | in-vivo, | AD, | NA |
| 2806- | CHr, | Se, | Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy |
| - | in-vitro, | Var, | NA |
| 2784- | CHr, | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
| - | Review, | Var, | NA |
| 1583- | Citrate, | Extracellular citrate and metabolic adaptations of cancer cells |
| - | Review, | NA, | NA |
| 1586- | Citrate, | Extracellular Citrate Is a Trojan Horse for Cancer Cells |
| - | in-vitro, | Liver, | HepG2 |
| 1582- | Citrate, | Clinical report: A patient with primary peritoneal mesothelioma that has improved after taking citric acid orally |
| - | Case Report, | PerC, | NA |
| 1581- | Citrate, | Hypothesis proved. . .citric acid (citrate) does improve cancer:A case of a patient suffering from medullary thyroid cancer |
| - | Case Report, | Thyroid, | NA |
| 1578- | Citrate, | Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update |
| - | Review, | Var, | NA |
| 1576- | Citrate, | Targeting citrate as a novel therapeutic strategy in cancer treatment |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid